Correlation Between Krebs Biochemicals and CCL Products

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and CCL Products at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and CCL Products into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and CCL Products Limited, you can compare the effects of market volatilities on Krebs Biochemicals and CCL Products and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of CCL Products. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and CCL Products.

Diversification Opportunities for Krebs Biochemicals and CCL Products

0.78
  Correlation Coefficient

Poor diversification

The 3 months correlation between Krebs and CCL is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and CCL Products Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CCL Products Limited and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with CCL Products. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CCL Products Limited has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and CCL Products go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and CCL Products

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 4.09 times more return on investment than CCL Products. However, Krebs Biochemicals is 4.09 times more volatile than CCL Products Limited. It trades about 0.16 of its potential returns per unit of risk. CCL Products Limited is currently generating about 0.36 per unit of risk. If you would invest  8,803  in Krebs Biochemicals and on September 12, 2024 and sell it today you would earn a total of  1,977  from holding Krebs Biochemicals and or generate 22.46% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Krebs Biochemicals and  vs.  CCL Products Limited

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
CCL Products Limited 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in CCL Products Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical and fundamental indicators, CCL Products may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Krebs Biochemicals and CCL Products Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and CCL Products

The main advantage of trading using opposite Krebs Biochemicals and CCL Products positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, CCL Products can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CCL Products will offset losses from the drop in CCL Products' long position.
The idea behind Krebs Biochemicals and and CCL Products Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk